Colorado poised to become second state with legalized ‘medicinal psychedelics’
Colorado looks set to legalize magic mushrooms in this week’s midterm elections, with the group…
Author: STAT
Listen: Biogen’s new CEO, how the midterms affect science, & a biotech bankruptcy
How can Biogen right the ship? What happened to that “red wave”? And what can…
STAT+: PACT Pharma’s personalized cancer treatments, powered by CRISPR, clear early safety hurdles
Two years ago, researchers at the University of Pennsylvania showed for the first time that…
STAT+: Pharmalittle: Biogen hires Viehbacher as its CEO; new dengue vaccine rolled out amid safety concerns
Top of the morning to you, and a fine one it is. Crystal clear blue…
STAT+: Biogen appoints former Sanofi executive Christopher Viehbacher as CEO
Biogen named Christopher Viehbacher, who formerly ran the French drug giant Sanofi, as its new…
.jpg)
STAT+: Seagen names longtime Novartis exec as new CEO
Seagen announced Thursday that it had hired a new CEO, naming pharmaceutical industry executive David…
STAT+: For its first two medicines, EQRx abandons its bold strategy to lower drug prices
Changing the way cancer drugs are priced in the U.S. is apparently even harder than…
Cuando el cuidado es un asunto familiar, el Alzheimer supone una pesada carga para los hijos y los cónyuges
Read in English | Leer en inglés. HARLINGEN, Texas — Aquí en el Valle del…
En la frontera entre Texas y México, nace un audaz plan para diversificar la investigación sobre el Alzheimer
Read in English | Leer en inglés. BROWNSVILLE, Texas — Gladys Maestre está en una…
Opinion: Health workers’ mental health: Addressing the invisible global pandemic
The World Health Organization defines mental health as a state of mental well-being in which…
Legal at one clinic, illegal at another: How abortion bans make gestational age even less precise
If you want to understand the fickleness of pregnancy and the American laws that regulate…
‘The tipping point is coming’: Unprecedented exodus of young life scientists is shaking up academia
SAN DIEGO — Rayyan Gorashi is keeping her options open. After all, she’s still a…
STAT+: Jeff Jonas leaves Sage Therapeutics to launch biotech incubator
Longtime Sage Therapeutics executive Jeff Jonas is leaving the biotech company to launch a biotech…
U.S. set to face third Covid winter without key tools and treatments
The country is heading into its third Covid winter without crucial tools we’ve relied on…
.jpg)
STAT+: FDA panel votes against Veru’s drug for severe Covid
An FDA advisory panel voted 5-to-8 to recommend rejecting a new drug for patients hospitalized…
In a first, a fatal enzyme deficiency is treated in the womb
To protect this child from the same genetic disease that killed two older siblings, treating…
STAT+: Clovis Oncology warns of likely bankruptcy filing following years of scandal and financial losses
Clovis Oncology, a maker of cancer drugs, warned Wednesday that it will likely file for…
STAT+: Pharmalittle: ADC backs off accelerated approval after FDA demands confirmatory trial; explaining the Supreme Court’s split on drug-patent cases
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Shares of Merrimack, a dormant drugmaker, soar after cancer drug succeeds in trial
Shares of Merrimack Pharmaceuticals, a shuttered drug company with no employees or any active research…
Opinion: Employing everyday public health efforts to respond to polio’s re-emergence
Ask most Americans to name a victim of polio and they’ll say President Franklin Delano…
Opinion: Listen: Covid is not a ‘racial equity success story’
The idea that the narrowing gap between Covid-19 deaths among white Americans and Americans of…
STAT+: Andreessen Horowitz partners with rural health system to give its companies a go-to pilot site
Innovative health tech startups with big ideas will not get very far if they cannot…
Vermont establishes a constitutional right to an abortion
WASHINGTON — Vermont will make abortion a constitutional right after voters overwhelmingly approved a ballot…
California bans flavored tobacco products, including vapes
WASHINGTON – On Tuesday, Californians overwhelmingly voted to ban all flavored tobacco products in the…
STAT+: Faze Medicines, a biotech focused on neurological diseases, is shutting down
A biotech company that hoped to use cell biology to address neurological disorders is shutting…
STAT+: The U.S. Supreme Court will review a contentious Amgen patent case, but not one involving Bristol. Why?
In a surprising move, the U.S. Supreme Court rejected a bid by a Bristol Myers…
Brain implants that translate paralyzed patients’ thoughts into speech creep closer to reality
In 2003, Pancho’s life changed forever. That’s when a car crash sent the 20-year-old farm…
STAT+: Talkspace names a new CEO as its stock price continues to struggle
Following a year of executive shakeups and business rejiggering, Talkspace’s third quarter earnings came with…
STAT+: Pharmalittle: Biogen mulls new options in its CEO hunt; NIH starts contacting universities about overdue trial results
Rise and shine, everyone, another busy day is on the way. This is especially true…
Elizabeth Holmes awaits sentencing after bid for new trial fails
SAN JOSE, Calif. (AP) — A federal judge rejected a bid for a new trial…
Opinion: Real-time data are needed to monitor health after disasters
Weather-related disasters like the millions of Floridians left without power by Hurricane Ian or the…
Opinion: The Supreme Court needs to uphold protection for Native American children
As an American Indian pediatrician working in my own tribal community, I know how important…
In Arizona’s race for governor, Kari Lake fans Republican fury over Fauci, fentanyl and gender-affirming care
TEMPE, AZ. — On a windy, warm November night, thousands of Arizona Democrats lined the…
STAT+: After years of lax oversight, the NIH is starting to contact institutions about unreported clinical trial results
In recent weeks, the U.S. National Institutes of Health has begun emailing academic institutions that…
‘We’re sick of watching women die’: In Michigan, doctors rally to protect abortion access
GRAND RAPIDS, Mich. — Doctors are on the frontlines of a political battle raging across…
STAT+: J&J’s Mammen out of the running for Biogen CEO post
Biogen is mulling new options in its search for a CEO after talks with a…
STAT+: Amid concerns over U.S. democracy, pharma helped finance committees that support election deniers
As Americans head to the polls, some candidates continue to deny the results of the…
Medicare’s midterm punts, MA marketing schemes, and a closer look at the Abiomed deal
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
Free sunscreen, ear plugs — and Covid shots? At the NASCAR race, vaccinations are still a tough sell
AVONDALE, Ariz. — Under the bright lights of the Phoenix Raceway, as a hundred thousand…
Opinion: Californians: To keep kids healthy, oppose sales of flavored nicotine products
Californians have an opportunity on Tuesday to protect the health of their children by voting…
STAT+: Pharmalittle: Some Lilly workers want transfers due to Indiana abortion law; GSK cancer drug flops in late-stage study
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: FDA places clinical hold on Verve Therapeutics gene-edting treatment
Verve Therapeutics said Monday that its experimental gene-editing treatment for a common form of heart…
Opinion: Trying to quit my job as an ER doctor gave me reasons to stay
The morning was crisp and still dark as I sat in my car in the…
STAT+: Microsoft’s note-taking tool asks doctors to make a grand bargain: Share patient data, and get your life back
The artificial intelligence system is a dream for many doctors: It records their conversations with…
Health and science are on the ballot this election. Here’s what we’re watching
WASHINGTON — The midterm elections this year are centered on weighty topics: the economy looms…
STAT+: Muscular dystrophy patient who was first in line for a custom CRISPR therapy dies
A man with muscular dystrophy who was first in line to receive an experimental gene…
STAT+: U.S. Supreme Court gives Amgen a boost by agreeing to review a closely watched patent case
In a boost for Amgen, the U.S. Supreme Court on Friday agreed to hear a…
STAT+: A ‘blank check’: Bill to boost antibiotic development blasted as a ‘flawed’ giveaway to pharma
Amid mounting concern over antibiotic resistance, a coalition of academics and advocacy groups is urging…
A letter from the executive editor: STAT turns 7
Dear Readers, Today, STAT turns 7. I’d like to express my gratitude to readers like…
STAT+: Pharmalittle: Europe approves a Sanofi and AstraZeneca RSV shot; CDC updates opioid prescribing guidelines
And so, another working week will soon draw to a close. Not a moment too…